INTC vs TERN · rev $52.85B vs $6.12B cap
Intel Corporation (INTC) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported INTC revenue for 2025-12-27 was $52.85B. Net income was -$267.0M. Revenue was down 0.5% from 2024-12-28 to 2025-12-27. INTC currently screens at market cap $498.43B.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
INTC currently screens at market cap $498.43B. TERN currently screens at market cap $6.12B.
Not investment advice. Open the INTC and TERN stock pages for the full models.
Not investment advice.